Denali Therapeutics Inc. Collaboration Agreements
3 Contracts & Agreements
- Definitive LRRK2 Collaboration and License Agreement (Filed With SEC on November 5, 2020)
- Provisional LRRK2 Collaboration and License Agreement between the Registrant and Biogen Inc., dated August 5, 2020 (Filed With SEC on November 5, 2020)
- Option and Collaboration Agreement between the Registrant and Takeda Pharmaceutical Company Limited, dated January 3, 2018 (Filed With SEC on March 19, 2018)
